Table 15.4a

Steroid Avoidance Rate at Discharge, 1997 to 2006

Recipients of Deceased Donor Kidneys

Discharge Regimen Year of Transplant
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Total Patients 6,306 6,527 6,480 6,402 6,708 6,977 7,131 7,600 8,076 8,585
Steroids Avoided 161 210 166 255 340 515 980 1,520 2,104 2,695
Rate 2.6% 3.2% 2.6% 4.0% 5.1% 7.4% 13.7% 20.0% 26.1% 31.4%
CyA Patients 420 384 349 214 104 92 105 114 51 38
Steroids Avoided 23 22 16 4 2 3 11 12 10 11
Rate 5.5% 5.7% 4.6% 1.9% 1.9% 3.3% 10.5% 10.5% 19.6% 28.9%
Tac Patients 187 176 197 233 340 395 221 277 358 288
Steroids Avoided 3 9 11 33 78 154 65 90 133 156
Rate 1.6% 5.1% 5.6% 14.2% 22.9% 39.0% 29.4% 32.5% 37.2% 54.2%
CyA+MMF Patients 3,237 3,347 3,162 2,523 1,969 1,774 1,516 1,281 903 780
Steroids Avoided 32 40 31 45 44 43 97 117 77 169
Rate 1.0% 1.2% 1.0% 1.8% 2.2% 2.4% 6.4% 9.1% 8.5% 21.7%
Tac+MMF Patients 733 1,172 1,642 1,993 2,624 3,335 3,745 4,607 5,663 6,363
Steroids Avoided 19 24 35 53 75 125 400 908 1,557 2,057
Rate 2.6% 2.0% 2.1% 2.7% 2.9% 3.7% 10.7% 19.7% 27.5% 32.3%
CyA+Aza Patients 906 577 366 233 122 56 32 14 9 7
Steroids Avoided 10 5 0 1 0 1 2 0 1 0
Rate 1.1% 0.9% 0.0% 0.4% 0.0% 1.8% 6.3% 0.0% 11.1% 0.0%
Tac+Aza Patients 141 122 79 54 84 60 48 26 24 27
Steroids Avoided 2 4 1 1 1 1 1 1 11 10
Rate 1.4% 3.3% 1.3% 1.9% 1.2% 1.7% 2.1% 3.8% 45.8% 37.0%
Siro+MMF Patients - 2 9 85 257 272 211 207 171 157
Steroids Avoided - 2 0 5 15 19 35 51 38 60
Rate - 100.0% 0.0% 5.9% 5.8% 7.0% 16.6% 24.6% 22.2% 38.2%
CyA+Siro Patients 123 220 120 303 294 187 222 212 164 123
Steroids Avoided 0 1 4 2 11 9 55 93 72 41
Rate 0.0% 0.5% 3.3% 0.7% 3.7% 4.8% 24.8% 43.9% 43.9% 33.3%
Tac+Siro Patients - - 11 302 452 339 440 330 213 253
Steroids Avoided - - 0 30 55 73 117 111 76 63
Rate - - 0.0% 9.9% 12.2% 21.5% 26.6% 33.6% 35.7% 24.9%
Other Regimen Patients 559 527 545 462 462 467 591 532 520 549
Steroids Avoided 72 103 68 81 59 87 197 137 129 128
Rate 12.9% 19.5% 12.5% 17.5% 12.8% 18.6% 33.3% 25.8% 24.8% 23.3%


Source: OPTN/SRTR Data as of May 1, 2007.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressive drug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.